195 related articles for article (PubMed ID: 36997451)
1. Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging Study.
Sacher J; Zsido RG; Barth C; Zientek F; Rullmann M; Luthardt J; Patt M; Becker GA; Rusjan P; Witte AV; Regenthal R; Koushik A; Kratzsch J; Decker B; Jogschies P; Villringer A; Hesse S; Sabri O
Biol Psychiatry; 2023 Jun; 93(12):1081-1088. PubMed ID: 36997451
[TBL] [Abstract][Full Text] [Related]
2. Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder.
Comasco E; Hahn A; Ganger S; Gingnell M; Bannbers E; Oreland L; Wikström J; Epperson CN; Lanzenberger R; Sundström-Poromaa I
Hum Brain Mapp; 2014 Sep; 35(9):4450-8. PubMed ID: 24615932
[TBL] [Abstract][Full Text] [Related]
3. The impact of depressed mood and coping motives on cannabis use quantity across the menstrual cycle in those with and without pre-menstrual dysphoric disorder.
Joyce KM; Thompson K; Good KP; Tibbo PG; O'Leary ME; Perrot TS; Hudson A; Stewart SH
Addiction; 2021 Oct; 116(10):2746-2758. PubMed ID: 33651443
[TBL] [Abstract][Full Text] [Related]
4. Trait-related changes in brain network topology in premenstrual dysphoric disorder.
Dan R; Reuveni I; Canetti L; Weinstock M; Segman R; Goelman G; Bonne O
Horm Behav; 2020 Aug; 124():104782. PubMed ID: 32470339
[TBL] [Abstract][Full Text] [Related]
5. Effects of cognitive emotion regulation strategies on mood and cortisol in daily life in women with premenstrual dysphoric disorder.
Nayman S; Beddig T; Reinhard I; Kuehner C
Psychol Med; 2023 Aug; 53(11):5342-5352. PubMed ID: 35979813
[TBL] [Abstract][Full Text] [Related]
6. Treatment of premenstrual dysphoric disorder with the GABA
Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
[TBL] [Abstract][Full Text] [Related]
7. The multifactorial aetiology and management of premenstrual dysphoric disorder with leuprorelin acetate.
Dunphy L; Boyle S; Wood F
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38160030
[TBL] [Abstract][Full Text] [Related]
8. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.
Timby E; Bäckström T; Nyberg S; Stenlund H; Wihlbäck AN; Bixo M
Psychopharmacology (Berl); 2016 Jun; 233(11):2109-2117. PubMed ID: 26960697
[TBL] [Abstract][Full Text] [Related]
9. Gonadotrophic hormone and reinforcement sensitivity systems in women with premenstrual dysphoric disorder.
Ko CH; Long CY; Yen CF; Chen CS; Wang PW; Yen JY
Psychiatry Clin Neurosci; 2014 Nov; 68(11):785-94. PubMed ID: 24735107
[TBL] [Abstract][Full Text] [Related]
10. The impact of competitive sports on menstrual cycle and menstrual disorders, including premenstrual syndrome, premenstrual dysphoric disorder and hormonal imbalances.
Czajkowska M; Drosdzol-Cop A; Naworska B; Galazka I; Gogola C; Rutkowska M; Skrzypulec-Plinta V
Ginekol Pol; 2020; 91(9):503-512. PubMed ID: 33030729
[TBL] [Abstract][Full Text] [Related]
11. The effect of serotonin 1A receptor polymorphism on the cognitive function of premenstrual dysphoric disorder.
Yen JY; Tu HP; Chen CS; Yen CF; Long CY; Ko CH
Eur Arch Psychiatry Clin Neurosci; 2014 Dec; 264(8):729-39. PubMed ID: 24158751
[TBL] [Abstract][Full Text] [Related]
12. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
Yonkers KA; Kornstein SG; Gueorguieva R; Merry B; Van Steenburgh K; Altemus M
JAMA Psychiatry; 2015 Oct; 72(10):1037-44. PubMed ID: 26351969
[TBL] [Abstract][Full Text] [Related]
13. New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder.
Sundström-Poromaa I; Comasco E
CNS Drugs; 2023 May; 37(5):371-379. PubMed ID: 37171547
[TBL] [Abstract][Full Text] [Related]
14. Menstrual Cycle and the Prevalence of Premenstrual Syndrome/Premenstrual Dysphoric Disorder in Adolescent Athletes.
Czajkowska M; Drosdzol-Cop A; Gałązka I; Naworska B; Skrzypulec-Plinta V
J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):492-8. PubMed ID: 26233292
[TBL] [Abstract][Full Text] [Related]
15. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).
Reed SC; Levin FR; Evans SM
Horm Behav; 2008 Jun; 54(1):185-93. PubMed ID: 18413151
[TBL] [Abstract][Full Text] [Related]
16. Cortical morphology variations during the menstrual cycle in individuals with and without premenstrual dysphoric disorder.
Dubol M; Stiernman L; Sundström-Poromaa I; Bixo M; Comasco E
J Affect Disord; 2024 Jun; 355():470-477. PubMed ID: 38552916
[TBL] [Abstract][Full Text] [Related]
17. Insomnia, Inattention and Fatigue Symptoms of Women with Premenstrual Dysphoric Disorder.
Lin PC; Ko CH; Lin YJ; Yen JY
Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34201084
[TBL] [Abstract][Full Text] [Related]
18. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
Itriyeva K
Curr Probl Pediatr Adolesc Health Care; 2022 May; 52(5):101187. PubMed ID: 35534402
[TBL] [Abstract][Full Text] [Related]
19. Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD).
Beddig T; Reinhard I; Kuehner C
Psychoneuroendocrinology; 2019 Nov; 109():104372. PubMed ID: 31357135
[TBL] [Abstract][Full Text] [Related]
20. Patient Experiences of Health Care Providers in Premenstrual Dysphoric Disorder: Examining the Role of Provider Specialty.
Hantsoo L; Sajid H; Murphy L; Buchert B; Barone J; Raja S; Eisenlohr-Moul T
J Womens Health (Larchmt); 2022 Jan; 31(1):100-109. PubMed ID: 33978482
[No Abstract] [Full Text] [Related]
[Next] [New Search]
